Abstract:Objective To identify the differential inflammation factors in nephroblastoma tissue using proteomics technology and analyze its relationship with clinical stage,pathological phenotype,lymph node metastasis,vascular invasion.Methods From Jan 2010 to Dec 2014,nephroblastoma tumor tissues from 40 patients were obtained.Meanwhile,the 35 tissue near proximal kidney and 25 tissues distal kidney were also obtained.The classification of clinical stage included Ⅰ stage in 6 cases,Ⅱ stage in 12 cases,Ⅲ stage in 13 cases and Ⅳ stage in 9 cases.Other characters contained good prognosis type in 37 case,poor prognosis type in 3 cases,lymphatic metastasis in 17 cases,no sign of lymphatic metastasis in 23 cases,vascular invasion in 9 cases and non-vascular invasion in 31 cases.The SELDI-TOF-MS was used for screening differential protein peaks among three groups.Then,SPE and TRICINE-SDS-PAGE were used to separate and purificate the protein,which showed high peaks expression in tumor tissue,respectively.After in-gel digestion,we received the identification of targeted proteins according to sequence information through Nano-LC-MS/MS.Finally we compared differential expression of inflammatory peaks in different groups of clinical stage,pathological type,lymph node metastasis and vascular invasion.Results All the peaks high expression in tumor tissue,m/z12138 and m/z 13462 are identified as MIF and NAP-2.Expression of two protein peaks in tumor tissue(1437.8 + 997.3,1730.4 + 1147.8) is higher than those in proximal tissue (952.6 + 591.2,1031.1 + 1120.8) and in distal tissue(315.4 + 296.5,114.7 + 118.9),which showed the significant difference (P ＜ 0.001).According to the clinic stage classification,the expression of those protein were 678.8 + 189.0,746.2 + 238.7 in stage Ⅰ,664.0 + 202.0,1180.7 + 404.9 in stage Ⅱ,1524.7+407.9,2160.4 + 1252.3 in stage Ⅲ and 2850.2 + 861.2,2498.4 + 1290.5 in stage Ⅳ.Based on the other characters,expression of those protein were the 1271.7 + 809.2,1553.3 + 991.4 in good prognosis type,3487.2 + 166.2,3915.1 +507.3 in poor prognosis type,2207.1 +961.7,2569.5 + 1285.2 in lymph node metastasis,869.2 + 474.6,1110.2 + 433.6 in non-lymph node metastasis,2850.2 + 861.2,2498.4 +1290.5 in vascular invasion and 1027.8 + 521.3,1507.5 + 1019.9 in non-vascular invasion.All the comparison results have significant statistical difference (P ＜ 0.001).Conclusion MIF and NAP-2significantly increase in nephroblastoma tumor tissue.Meanwhile,there was obvious relationship between those protein with clinical stage,pathological type,lymph node metastasis and vascular invasion.

Differential analysis of two-dimensional gel electrophoresis profile of human non-muscle-invasive bladder cancer and invasive bladder cancer tissue

Microfluidic Assaying of Circulating Tumor Cells and its Correlation with Muscle Invasiveness and Tumor Grade of Urothelial Bladder Cancer

Characterization of Texture Features Between Carcinomatous and Normal Wall Tissue in MR Bladder Imaging

Proteome analysis and tissue microarray for profiling protein markers associated with lymph node metastasis in colorectal cancer.

Differential analysis of two-dimensional gel electrophoresis profile of pancreatic ductal adenocarcinoma and adjacent tissue

Research of Differential Proteomics in Prostate Cancer by Two-Dimensional Polyacrylamide Gel Electrophoresis and Mass Spectrometry

Comparative proteomic study for profiling differentially expressed proteins between Chinese left- and right-sided colon cancers.

[Differential Analysis of Two-Dimension Gel Electrophoresis Profiles of Human Lung Squamous Carcinoma and Tumor-Adjacent Tissue].

Differential expression and significance of apolipoprotein A1 and zinc-alpha-2-glycoprotein in serum of patients with bladder transitional cell carcinoma

Identification of differential inflammation factors in nephroblastoma tissue and clinical significance

Gene expression profile and enrichment pathways in different stages of bladder cancer

Comprehensive Analysis of Differential Gene Expression and Correlated Immune Infiltration in Bladder Cancer

Tree Analysis of Mass Spectral Urine Profiles Discriminates Transitional Cell Carcinoma of the Bladder from Noncancer Patient

Two-dimensional gel electrophoresis in screen and identification of differentially expressed proteins between patients with small renal cell carcinoma and healthy controls

Proteomic analysis of non‐muscle invasive and muscle invasive bladder cancer highlights distinct subgroups with metabolic, matrisomal, and immune hallmarks and emphasizes importance of the stromal compartment

A novel signature constructed by differential genes of muscle-invasive and non-muscle-invasive bladder cancer for the prediction of prognosis in bladder cancer

SPECIFIC GENE SET SCORES IN PROGNOSTIC PREDICTION OF MUSCLE INVASIVE BLADDER CANCER

Differential Expressed Profile of Proteins in Normal Tissue and Pancreatic Cancer Using Proteomic Approaches

A Comprehensive Investigation Toward the Indicative Proteins of Bladder Cancer in Urine: from Surveying Cell Secretomes to Verifying Urine Proteins.

Comparative proteome analysis of human lung squamous cell carcinoma

Diferential analysis of two-dimensional gel electrophoresis profiles for oral squamous cell carcinoma.